Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-05-27
1998-07-07
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514885, 514908, A61K 3140
Patent
active
057769664
ABSTRACT:
Treatment with a set of porphyrin compounds using a photodynamic therapy approach is able selectively to lower elevated levels of activated leukocytes in a leukocyte population. This is particularly helpful in subjects containing such elevated levels of T-cell subsets, such as HIV-infected subjects.
REFERENCES:
patent: 4610241 (1986-09-01), Gordon
patent: 4960408 (1990-10-01), Klainer et al.
patent: 5028594 (1991-07-01), Carson
patent: 5087636 (1992-02-01), Jamieson et al.
patent: 5095030 (1992-03-01), Levy et al.
patent: 5149708 (1992-09-01), Dolphin et al.
patent: 5171749 (1992-12-01), Levy et al.
patent: 5190966 (1993-03-01), Dougherty et al.
patent: 5214036 (1993-05-01), Allison et al.
Gruner et al., "Inhibition of HLA-DR Antigen Expression and of the Allogeneic Mixed Leukocyte Reaction by Photochemical Treatment", Tissue Antigens 27, 147 and 151-154 (1986).
North et al., "Photodynamic Inactivation of Retrovirus by Benzoporphyrin Derivative: a Feline Leukemia Virus Model", Transfusion 32, 121-28 (1992).
North et al., "Photoinactivation of Human Immunodeficiency Virus (HIV) by Benzoporphyrin Derivative", Cell Biochem., Supp., Part E, 85, Abstract Q 545 (1992); and.
Matthews et al., "Preliminary Studies of Photoinactivation of Human Immunodeficiency Virus in Blood", Transfusion 31, 636-41 (1991).
Zarling et al., J. Immunol. (1990) 144:2992-2998.
Zuckerman et al., "Treatment of Antigen-induced Arthritis in Rabbits with Dysprosium-165-Ferric Hydroxide Macroaggregates", J. of Orthopaedic Res., 7:50-60 (1989).
Burn Brian M.
Quadra Logic Technologies Inc.
Raymond Richard L.
University of British Columbia
LandOfFree
Selective cell inactivation in blood does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective cell inactivation in blood, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective cell inactivation in blood will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1206412